No genes were uniquely mutated in any of the tumours of patients with a relapse, while only one gene, HERC2, was uniquely mutated in the primaries of 4/18 nonrecurrent patients and in none of the primaries or recurrences of patients with relapses (p = 0.1). This evidence concerns the gene HERC2 and neoplasm.